Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2020-01-24FDA Approved: INVOKANA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Invokana (canagliflozin) from Janssen Pharmaceuticals, Inc.
-
FDA label_change · 2020-01-24FDA Approved: SYNJARDY — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approved a supplemental application for SYNJARDY (empagliflozin and metformin hydrochloride) submitted by Boehringer Ingelheim to update…
-
FDA approval · 2020-01-24FDA Approved: SYNJARDY XR — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approved a supplemental application for SYNJARDY XR (empagliflozin/metformin hydrochloride) from Boehringer Ingelheim Pharmaceuticals, I…
-
FDA approval · 2020-01-24FDA Approved: STEGLATRO — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA approved a supplemental application for STEGLATRO (ertugliflozin) filed by Merck Sharp & Dohme LLC, resulting in changes to the drug…
-
FDA approval · 2020-01-24FDA Approved: SEGLUROMET — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA approved a supplemental application for Segluromet (ertugliflozin and metformin hydrochloride) from Merck Sharp & Dohme LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-01-22Clinical Trial Update: Dose-finding of PB-119 Administered Subcutaneously Once-weekly Versus Placebo in Drug-naïve T2DM Subjects [Phase 2]
Phase 2 dose-finding trial of PB-119 given subcutaneously weekly vs placebo in drug-naïve type 2 diabetes patients completed.
-
CLINICAL_TRIALS trial_result · 2020-01-22Clinical Trial Update: Dose-finding of PB-119 Administered Subcutaneously Once Weekly Versus Placebo in Subjects With Type 2 Diabetes [Phase 2]
Phase 2 dose-finding trial evaluating weekly subcutaneous PB-119 versus placebo in adults with type 2 diabetes completed.
-
CLINICAL_TRIALS trial_result · 2020-01-22Clinical Trial Update: Glucose Containing and Glucose Free Hemodialysate in Type 2 Diabetic Patients [Phase 4]
Phase 4 clinical trial update comparing glucose-containing and glucose-free hemodialysate in patients with type 2 diabetes and end-stage kid…
-
CLINICAL_TRIALS trial_result · 2020-01-22Clinical Trial Update: Cynara Scolymus Extract for Treatment of Diabetes Mellitus Type 2 [Phase 3]
Phase 3 trial update for Cynara scolymus extract as a treatment for Type 2 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2020-01-21Clinical Trial Update: Linagliptin Add-on to Insulin Background Therapy [Phase 3]
Phase 3 trial evaluating linagliptin added to insulin background therapy in type 2 diabetes; results completed with posted data.
-
CLINICAL_TRIALS trial_result · 2020-01-18Clinical Trial Update: Insulin Schemes for Type 2 Diabetes Control [Phase 4]
Phase 4 trial update on insulin schemes for type 2 diabetes control has completed with posted results.
-
FDA approval · 2020-01-16FDA Approved: OZEMPIC — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for Ozempic (semaglutide) by Novo Nordisk.
-
FDA approval · 2020-01-16FDA Approved: OZEMPIC — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for Ozempic to include an oral semaglutide formulation, expanding the product's delivery options…
-
CLINICAL_TRIALS trial_result · 2020-01-14Clinical Trial Update: PROTOCOL 3: Role of the Renal Nerves in the Increase in EGP in Response to Glucosuria [Phase 4]
A Phase 4 trial investigating the role of renal nerves on endogenous glucose production in response to glucosuria in adults with Type 2 diab…
-
CLINICAL_TRIALS withdrawal · 2020-01-14Clinical Trial Update: Ertugliflozin Versus Hydrochlorothiazide in Reducing Sympathetic Neural Overactivity in Patients With Hypertension and Recently-diagnosed Type 2 Diabetes. [Phase 4]
Phase 4 trial comparing ertugliflozin to hydrochlorothiazide for reducing sympathetic neural overactivity in patients with hypertension and …
-
CLINICAL_TRIALS trial_result · 2020-01-13Clinical Trial Update: Efficacy and Safety of Soliqua Versus Lantus in Ethnically/Racially Diverse Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Basal Insulin and Oral Antidiabetic Agents [Phase 3]
Phase 3 trial comparing Soliqua to Lantus in ethnically diverse patients with type 2 diabetes uncontrolled on basal insulin and oral agents;…
-
CLINICAL_TRIALS trial_result · 2020-01-13Clinical Trial Update: Study of MEDI0382 in Combination With Dapagliflozin and Metformin in Overweight/Obese Participants With Type 2 Diabetes [Phase 2]
Phase 2 trial studying MEDI0382 in combination with dapagliflozin and metformin in overweight/obese adults with type 2 diabetes; trial compl…
-
CLINICAL_TRIALS trial_result · 2020-01-13Clinical Trial Update: Examination of the Anti-inflammatory and Insulin Sensitizing Properties of Doxycycline in Humans [Phase 4]
Phase 4 clinical trial update examining doxycycline for anti-inflammatory and insulin-sensitizing effects in humans with type 2 diabetes and…
-
CLINICAL_TRIALS trial_result · 2020-01-10Clinical Trial Update: Evaluation of Losartan and Perindopril in Blacks Type 2 Diabetics Patients [Phase 4]
Phase 4 trial evaluating losartan and perindopril in Black patients with Type 2 Diabetes Mellitus has completed.
-
CLINICAL_TRIALS trial_result · 2020-01-10Clinical Trial Update: The Cardiovascular Effects of Ginger (Zingiber Officinale) in Patients With Type II Diabetes Mellitus [Phase 4]
Phase 4 trial updating on cardiovascular effects of ginger (Zingiber officinale) as add-on therapy in patients with type 2 diabetes mellitus…
-
CLINICAL_TRIALS trial_result · 2020-01-07Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Participants With Type 2 Diabetes Mellitus [Phase 2]
Phase 2 trial update for JNJ-64565111 in severely obese participants with type 2 diabetes completed with posted results.
-
CLINICAL_TRIALS research · 2020-01-07Clinical Trial Update: CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes [Phase 3]
Clinical trial update for CAROLINA comparing linagliptin vs glimepiride in type 2 diabetes; study completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-01-02Clinical Trial Update: A Patient-Centered Strategy for Improving Diabetes Prevention in Urban American Indians [NA]
A completed clinical trial evaluating a patient-centered strategy to prevent type 2 diabetes in urban American Indian populations; results h…
-
CLINICAL_TRIALS trial_result · 2019-12-30Clinical Trial Update: Dose-response, Safety and Efficacy of Oral Semaglutide Versus Placebo and Versus Liraglutide, All as Monotherapy in Japanese Subjects With Type 2 Diabetes [Phase 3]
Phase 3 trial comparing oral semaglutide to placebo and to liraglutide as monotherapy in Japanese adults with type 2 diabetes; results compl…
-
CLINICAL_TRIALS trial_result · 2019-12-30Clinical Trial Update: Safety and Efficacy of Oral Semaglutide Versus Dulaglutide Both in Combination With One OAD (Oral Antidiabetic Drug) in Japanese Subjects With Type 2 Diabetes [Phase 3]
Phase 3 trial comparing oral semaglutide to dulaglutide, both with one oral antidiabetic drug, in Japanese subjects with type 2 diabetes; re…